Cocaine modulates dendritic cell-specific C type intercellular adhesion molecule-3-grabbing nonintegrin expression by dendritic cells in HIV-1 patients

Journal of Immunology

Volumn 174, Issue 11, 2005, Pages 6617-6626

  Nair, Madhavan P N ^b   Mahajan, Supriya D ^a   Schwartz, Stanley A ^a   Reynolds, Jessica ^a   Whitney, Robert ^a   Bernstein, Zall ^a   Chawda, Ram P ^a   Sykes, Don ^a   Hewitt, Ross ^a   Hsiao, Chiu Bin ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b BUFFALO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; B7 ANTIGEN; BENZOYLECGONINE; CD209 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; COCAINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; GLYCOPROTEIN GP 120; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE COURSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS REPLICATION;

EID: 21044443286     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.11.6617     Document Type: Article

References (45)

1. Baribaud, F., S. Pohlmann, and R. W. Doms. 2001. The role of DC-SIGN and DC-SIGNR in HIV and SIV attachment, infection, and transmission. Virology 286: 1-6.
2. Geijtenbeek, T. B., and Y. van Kooyk. 2003. DC-SIGN: a novel HIV receptor on DCs that mediates HIV-1 transmission. Curr. Top. Microbiol. Immunol. 276: 31-54.
3. Pohlmann, S., F. Baribaud, and R. W. Doms. 2001. DC-SIGN and DC-SIGNR: helping hands for HIV. Trends Immunol. 22: 643-646.
4. Pohlmann, S., G. J. Leslie, T. G. Edwards, T. Macfarlan, J. D. Reeves. K. Hiebenthal-Millow, F. Kirchhoff, F. Baribaud, and R. W. Doms. 2001. DC-SIGN interactions with human immunodeficiency virus: virus binding and transfer are dissociable functions. J. Virol. 75: 10523-10526.
5. Pohlmann, S., E. J. Soilleux, F. Baribaud, G. J. Leslie, L. S. Morris, J. Trowsdale, B. Lee, N. Coleman, and R. W. Doms. 2001. DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and immunodeficiency viruses and activates infection in trans. Proc. Natl. Acad. Sci. USA 98: 2670-265.
6. Bashirova, A. A., T. B. Geijtenbeek, G. C. van Duijnhoven, S. J. van Vliet, J. B. Eilering, M. P. Martin, L. Wu, T. D. Martin, N. Viebig, P. A. Knolle, et al. 2001. A dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection. J. Exp. Med. 193: 671-678.
7. Geijtenbeek, T. B., R. Torensma, S. J. van Vliet, G. C. van Duijnhoven, G. J. Adema, Y. van Kooyk, and C. G. Figdor. 2000. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100: 575-585.
8. Bashirova, A. A., L. Wu, J. Cheng, T. D. Martin, M. P. Martin, R. E. Benveniste, J. D. Lifson, V. N. Kewal-Ramani, A. Hughes, and M. Carrington. 2003. Novel member of the CD209 (DC-SIGN) gene family in primates. J. Virol. 77: 217-227.
9. Soilleux, E. J. 2003. DC-SIGN (dendritic cell-specific ICAM-grabbing non-integrin) and DC-SIGN-related (DC-SIGNR): friend or foe? Clin. Sci. 104: 437-446.
10. Curtis, B. M., S. Scharnowske, and A. J. Watson. 1992. Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. Proc. Natl. Acad. Sci. USA 89: 8356-8360.
11. SAMHSA, Office of Applied Studies. 2003. National Household Survey on Drug Abuse, 2003.
12. Des Jarlais, D. 1988. Current epidemiology of AIDS among i.v. drug users in New York City. NIDA Res. Monogr. 90: 311-313.
13. Des Jarlais, D. C., and S. R. Friedman. 1988. HIV infection among persons who inject illicit drugs: problems and prospects. J. Acquired Immune Defic. Syndr. 1: 267-273.
14. Des Jarlais, D. C., and S. R. Friedman. 1988. Intravenous cocaine, crack, and HIV infection. J. Am. Med. Assoc. 259: 1945-1946.
15. Schwartz, S. A., and M. P. N. Nair. 1999. Current concepts in human immunodeficiency virus infections and AIDS. Clin. Diag. Lab. Immunol. 6: 295-305
16. Martinez, F., and R. R. Watson. 1990. Effects of cocaine and morphine on IgG production by human peripheral blood lymphocytes in vitro. Life Sci. 47: PL59-PL64.
17. Kim, Y. T., E. M. Hersh, and K. T. Trevor. 2003. Feasibility to generate monocyte-derived dendritic cell from coculture with melanoma tumor cells in the presence of granulocyte/macrophage colony-stimulating factor (GM-CSF) and interleukin-4. Am. J. Reprod. Immunol. 49: 230-238.
18. + leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4. J. Leukocyte Biol. 59: 208-218.
19. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179: 1109-1118.
20. Hart, D. N. 1997. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 90: 3245-3287.
21. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9: 271-296.
22. Steinman, R. M. 2000. DC-SIGN: a guide to some mysteries of dendritic cells. Cell 100: 491-494.
23. + dendritic cells. Proc. Natl. Acad. Sci. USA 93: 2588-2592.
24. Kashanchi, F., R. Shibata, E. K. Ross, J. N. Brady, and M. A. Martin. 1994. Second-site long terminal repeat (LTR) revenants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA. J. Virol. 68: 3298-3307.
25. Kashanchi, F., J. F. Duvall, and J. N. Brady. 1992. Electroporation of viral transactivator proteins into lymphocyte suspension cells. Nucleic Acids Res. 20: 4673-464.
26. Schols, D., P. Proost, J. Van Damme, and E. De Clercq. 1997. RANTES and MCP-3 inhibit the replication of T-cell-tropic human immunodeficiency virus type 1 strains (SF-2, MN, and HE). J. Virol. 71: 7300-734.
27. + T-cell reactivity by dendritic cells loaded with HIV-1 X4-infected apoptotic cells. J. Virol. 76: 3007-3014.
28. Chomczynski, P., and N. Saachi, 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159
29. Shively, L., L. Chang, J. M. LeBon, Q. Liu, A. D. Riggs, and J. Singer-Sam. 2003. Real-time PCR assay for quantitative mismatch detection. BioTechniques 34: 498-502, 504.
30. Coligan, J. E., A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. 1991. Current Protocols in Imunology. pp. 145-186.
31. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76: 4350-434.
32. Turville, S. G., P. U. Cameron, A. Handley, G. Lin, S. Pöhlmann, R. W. Doms and A. L. Cunningham. 2002. Diversity of receptors binding HIV on dendritic cell subsets. Nat. Immunol. 3: 975-983.
33. + T cells. J. Immunol. 164: 4018-4024.
34. Frank, I., L. Kacani, H. Stoiber, H. Stossel, M. Spruth, F. Steindl, N. Romani, and M. P. Dierich. 1999. Human immunodeficiency virus type 1 derived from cocultures of immature dendritic cells with autologous T cells carries T-cell-specific molecules on its surface and is highly infectious. J. Virol. 73: 3449-3454.
35. Ganesh, L., K. Leung, K. Lore, R. Levin, A. Panet, O. Schwartz, R. A. Koup, and G. J. Nabel. 2004. Infection of specific dendritic cells by CCR5-tropic human immunodeficiency virus type 1 promotes cell-mediated transmission of virus resistant to broadly neutralizing antibodies. J. Virol. 78: 11980-11987.
36. Pellegrino, T., and B. M. Bayer. 1998. In vivo effects of cocaine on immune cell function. J. Neuroimmunol. 83: 139-147.
37. Brettle, R. P., A. Chiswick, J. Bell, A. Busuttil, A. Wilson, S. Povey, and C. L. Leen. 1997. Pre-AIDS deaths in HIV infection related to intravenous drug use. QJM 90: 617-629.
38. Bender, A., M. Sapp, G. Schuler, R. M. Steinman, and N. Bhardwaj. 1996. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Methods 196: 121-135.
39. Cella, M., A. Engering, V. Pinet, J. Pieters, and A. Lanzavecchia. 1997. Inflammatory stimuli induce accumulation of MHC class II complexes on DC. Nature 388: 782-787.
40. Romani, N., S. Gruner, D. Brang, E. Kampgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P. O. Fritsch, R. M. Steinman, and G. Schuler. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180: 83-93.
41. Granelli-Piperno, A., E. Delgado, V. Finkel, W. Paxton, and R. M. Steinman. 1998. Immature DC selectively replicate macrophagetropic (M-tropic) human immunodeficiency virus type 1, while mature cells efficiently transmit both M- and T-tropic virus to T cells J. Virol. 72: 2733-2737.
42. Cameron, P., M. Pope, A. Granelli-Piperno, and R. M. Steinman. 1996. Dendritic cells and the replication of HIV-1. J. Leukocyte Biol. 59: 158-171.
43. Fanales-Belasio, E., S. Moretti, F. Nappi, G. Barillari, F. Micheletti, A. Cafaro, and B. Ensoli. 2002. Native HIV-1 Tat protein targets monocyte-derived dendritic cells and enhances their maturation, function, and antigen-specific T cell responses. J. Immunol. 168: 197-206.
44. Sibley, D. R., F. J. Monsma, Jr., and Y. Shen. 1993. Molecular neurobiology of dopaminergic receptors. Int. Rev. Neurobiol 35: 391-415.
45. Anderson, S. M., A. A. Bari, and R. C. Pierce. 2003. Administration of the D1-like dopamine receptor antagonist SCH-23390 into the medial nucleus accumbens shell attenuates cocaine priming-induced reinstatement of drug-seeking behavior in rats. Psychopharmacology 168: 132-138.